title: Lessons from the national emphysema treatment trial.
abstract: Medicare coverage for lung volume reduction surgery has been approved recently by the Centers for Medicare and Medicaid Services for the treatment of severe emphysema. The scientific basis for this approval stems largely from findings of the National Emphysema Treatment Trial (NETT). The purpose of this article is to review the contributions of the NETT to the management of chronic obstructive pulmonary disease.
authors.affiliation: Department of Surgery, Section of Thoracic Surgery, University of Michigan Health System, Ann Arbor, Michigan 48109, USA. andrwchg@umich.edu
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Chang
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Chan
authors.forename: Fernando J
authors.initials: FJ
authors.lastname: Martinez
mesh_terms: D002986:Clinical Trials as Topic; D006801:Humans; D011013:Pneumonectomy / Q000379:methods*; D011656:Pulmonary Emphysema / Q000601:surgery*; D016896:Treatment Outcome; D014481:United States